Condition

Primary Graft Dysfunction clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Primary Graft Dysfunction clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Canada (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Primary Graft Dysfunction clinical trials

StudyPhaseWhereStatusRegistered
Temperature-controlled heart preservation system vs ice for primary graft dysfunction — Toronto, Ontario Recruiting Nov 17, 2025
CCR5 immune blockade to prevent primary graft dysfunction after lung transplant Phase 2 San Francisco, California Recruiting Feb 28, 2025
Analyzing risk factors for lung transplant complications — Philadelphia, Pennsylvania Recruiting Nov 1, 2007

All recruiting trials (3)

Related topics

Lung TransplantationAcute Lung Injury(ALI)

Quick answers

How many Primary Graft Dysfunction clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.